DYRK1A and Alzheimer disease: Competition of [18F]MK-6240 with the DYRK1A inhibitor, KuFal194 exhibited nonsignificant effect, suggesting that [18F]MK-6240 does not bind to the phosphokinase, if present, in both AD and DSAD cases.